Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19

Lipopeptide-19, a HIV fusion inhibitor (LP-19), has showed potent anti-HIV activity. However, there is still limited information of the antiviral activity against different subtype clinical isolates and the drug resistance barrier of LP-19. Therefore, 47 HIV clinical isolates were selected for this...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lin, Wang, Chen, Zhang, Yuanyuan, Chong, Huihui, Hu, Xiaoyan, Li, Dan, Xing, Hui, He, Yuxian, Shao, Yiming, Hong, Kunxue, Ma, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225588/
https://www.ncbi.nlm.nih.gov/pubmed/37256122
http://dx.doi.org/10.3389/fimmu.2023.1199938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225588/
https://www.ncbi.nlm.nih.gov/pubmed/37256122
http://dx.doi.org/10.3389/fimmu.2023.1199938

Ejemplares similares